(Q35636528)

9 August 2017

title

Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America (English)

1 reference

9 August 2017

0 references

0 references

0 references

congenital toxoplasmosis

1 reference

6

J P Dubey

1 reference

9 August 2017

Kenneth Boyer

1

1 reference

9 August 2017

Dolores Hill

2

1 reference

9 August 2017

Ernest Mui

3

1 reference

9 August 2017

Kristen Wroblewski

4

1 reference

9 August 2017

Theodore Karrison

5

1 reference

9 August 2017

Mari Sautter

7

1 reference

9 August 2017

A Gwendolyn Noble

8

1 reference

9 August 2017

Shawn Withers

9

1 reference

9 August 2017

Charles Swisher

10

1 reference

9 August 2017

Peter Heydemann

11

1 reference

9 August 2017

Tiffany Hosten

12

1 reference

9 August 2017

Jane Babiarz

13

1 reference

9 August 2017

Daniel Lee

14

1 reference

9 August 2017

Paul Meier

15

1 reference

9 August 2017

Rima McLeod

16

1 reference

9 August 2017

Toxoplasmosis Study Group

17

1 reference

9 August 2017

language of work or name

English

0 references

publication date

21 October 2011

1 reference

Clinical Infectious Diseases

9 August 2017

published in

1 reference

9 August 2017

volume

53

1 reference

9 August 2017

issue

11

1 reference

9 August 2017

page(s)

1081-1089

1 reference

Identification of a sporozoite-specific antigen from Toxoplasma gondii

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Clinical manifestations of ocular toxoplasmosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restri

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Why prevent, diagnose and treat congenital toxoplasmosis?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Host genetic and epigenetic factors in toxoplasmosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Longitudinal study of new eye lesions in children with toxoplasmosis who were not treated during the first year of life

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Cataracts in congenital toxoplasmosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Biology and epidemiology of Toxoplasma gondii in man and animals

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Humane strategies for controlling feral cat populations

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Epidemic toxoplasmosis associated with infected cats

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Impact of visual impairment on measures of cognitive function for children with congenital toxoplasmosis: implications for compensatory intervention strategies.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

HLA-class II genes modify outcome of Toxoplasma gondii infection.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Neurologic and developmental outcome in treated congenital toxoplasmosis.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3246875

Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening

25 September 2018

1 reference

12 December 2020

Eye manifestations of congenital toxoplasmosis

1 reference

12 December 2020

Ocular toxoplasmosis; pathogenesis, diagnosis and treatment

1 reference

12 December 2020

Longitudinal study of new eye lesions in treated congenital toxoplasmosis

1 reference

12 December 2020

Acquired toxoplasmosis. (Study of 227 cases)

1 reference

12 December 2020

Identifiers

DOI

10.1093/CID/CIR667

1 reference

9 August 2017

1 reference

9 August 2017

1 reference